Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Raloxifene administration in post-menopausal women with osteoporosis: effect of different BsmI vitamin D receptor genotypes.

Human reproduction (Oxford, England) - 1 Jan 2003

Palomba Stefano, Numis Fabio Giuliano, Mossetti Giuseppe, Rendina Domenico, Vuotto Pietro, Russo Tiziana, Zullo Fulvio, Nappi Carmine, Nunziata Vincenzo

Abstract excerpt

BACKGROUND: The vitamin D receptor (VDR) gene polymorphism has been considered a factor influencing the effectiveness of the anti-osteoporotic treatments. The aim of this study was to correlate the effectiveness of raloxifene treatment in post-menopausal women with osteoporosis to BsmI VDR genotypes. METHODS: Between January and August 2000, 75 Italian osteoporotic women were enrolled and treated with raloxifene...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Amino Acids
Share to Bone Density

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Double-Blind Method

Share to Lumbar Vertebrae

Share to Osteocalcin

Share to Osteoporosis, Postmenopausal

Share to Receptors, Calcitriol

Share to Selective Estrogen Receptor Modulators

Source

Identifiers

PMID: 12525466
DOI: 10.1093/humrep/deg031

Genes

VDR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Raloxifene administration in post-menopausal women with osteoporosis: effect of different BsmI vitamin D receptor genotypes.PMID 12525466Read ↗

BsmI vitamin D receptor genotypes influence the efficacy of antiresorptive treatments in postmenopausal osteoporotic women. A 1-year multicenter, randomized and controlled trial.Semantic proximity Read ↗

The effect of vitamin D receptor BsmI genotype on the response to osteoporosis treatment in postmenopausal women: a pilot study.Semantic proximity Read ↗

Vitamin D receptor alleles and bone mineral density in a normal premenopausal Brazilian female population.Semantic proximity Read ↗

VDR genotype and response to etidronate therapy in late postmenopausal women.Semantic proximity Read ↗

Vitamin D receptor BsmI polymorphism and osteoporosis risk: a meta-analysis from 26 studies.Semantic proximity Read ↗

Vitamin D Receptor Gene Polymorphisms Affect Osteoporosis-Related Traits and Response to Antiresorptive TherapySemantic proximity Read ↗

Influence of the BsmI polymorphism of the vitamin D receptor gene on rheumatoid arthritis clinical activity.Semantic proximity Read ↗

Does the vitamin D receptor genotype predict bone mineral loss in haemodialysed patients?Semantic proximity Read ↗

Relation of BsmI vitamin D receptor gene polymorphism to bone mineral density and occurrence of osteoporosis in postmenopausal Chinese women in Taiwan.Semantic proximity Read ↗

Vitamin D receptor gene polymorphisms in a group of postmenopausal Turkish women: association wıth bone mineral density.Semantic proximity Read ↗

The vitamin D receptor gene BsmI polymorphism is not associated with anthropometric and biochemical parameters describing metabolic syndrome in postmenopausal women.Semantic proximity Read ↗

Vitamin D receptor gene polymorphisms and bone mineral density in postmenopausal Indian women.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.